These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7818565)
1. Inhibition of complement activation by intravenous immunoglobulins. Qi M; Schifferli JA Arthritis Rheum; 1995 Jan; 38(1):146. PubMed ID: 7818565 [No Abstract] [Full Text] [Related]
2. Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition. Basta M Mol Immunol; 2008 Oct; 45(16):4073-9. PubMed ID: 18706699 [TBL] [Abstract][Full Text] [Related]
3. IVIg inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN. Piepers S; Jansen MD; Cats EA; van Sorge NM; van den Berg LH; van der Pol WL J Neuroimmunol; 2010 Dec; 229(1-2):256-62. PubMed ID: 20920831 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation. Lutz HU; Späth PJ Clin Rev Allergy Immunol; 2005 Dec; 29(3):207-12. PubMed ID: 16391395 [TBL] [Abstract][Full Text] [Related]
5. The role of complement in immunohematology. Giles CM Transfusion; 1989; 29(9):803-11. PubMed ID: 2686108 [No Abstract] [Full Text] [Related]
6. Molecular organization and function of the complement system. Müller-Eberhard HJ Annu Rev Biochem; 1988; 57():321-47. PubMed ID: 3052276 [No Abstract] [Full Text] [Related]
7. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum. Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276 [TBL] [Abstract][Full Text] [Related]
8. Activation and control of the complement system. Reid KB Essays Biochem; 1986; 22():27-68. PubMed ID: 3549286 [No Abstract] [Full Text] [Related]
9. [Complement: mechanisms of activation, functions, analysis]. Dessaint JP; Wattre P; Santoro F; Capron A Lille Med; 1979; 24(7):551-8. PubMed ID: 397392 [No Abstract] [Full Text] [Related]
10. Complement deposition induced by binding of anti-contactin-1 auto-antibodies is modified by immunoglobulins. Appeltshauser L; Weishaupt A; Sommer C; Doppler K Exp Neurol; 2017 Jan; 287(Pt 1):84-90. PubMed ID: 27746185 [TBL] [Abstract][Full Text] [Related]
11. Statin drugs do not affect serum complement activation in vitro. Lappegård KT; Hvassing T; Mollnes TE Scand J Immunol; 2004; 60(1-2):178-83. PubMed ID: 15238087 [TBL] [Abstract][Full Text] [Related]
12. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system]. Lesavre P; Leibowitch J Nouv Presse Med; 1979 Jun; 8(29):2385-7. PubMed ID: 493022 [No Abstract] [Full Text] [Related]
13. Physiology and pathophysiology of complement: progress and trends. Morgan BP Crit Rev Clin Lab Sci; 1995; 32(3):265-98. PubMed ID: 7495498 [TBL] [Abstract][Full Text] [Related]
14. Role of complement and complement regulatory proteins in glomerulonephritis. Quigg RJ Springer Semin Immunopathol; 2003 May; 24(4):395-410. PubMed ID: 12778335 [No Abstract] [Full Text] [Related]
15. Complement. Historical perspectives and some current issues. Mayer MM Complement; 1984; 1(1):2-26. PubMed ID: 6100484 [No Abstract] [Full Text] [Related]
16. Pharmacological manipulation of the complement system in human diseases. Asghar SS Front Biosci; 1996 Mar; 1():e15-25. PubMed ID: 9159241 [TBL] [Abstract][Full Text] [Related]